(Q28299667)

https://api.crossref.org/works/10.1038%2FNCPONC0794

Gli1 is important for medulloblastoma formation in Ptc1+/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

APC mutations in sporadic medulloblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

"Large cell/anaplastic" medulloblastomas: a Pediatric Oncology Group Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

Trends in cancer incidence among children in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Brain and other central nervous system tumors: rates, trends, and epidemiology.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Prediction of central nervous system embryonal tumour outcome based on gene expression

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Genetic regulation of cerebellar development

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Morphing into cancer: the role of developmental signaling pathways in brain tumor formation

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Medulloblastoma: developmental mechanisms out of control

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

The hedgehog pathway and neurological disorders

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Transcriptional profiling of the Sonic hedgehog response: a critical role for N-myc in proliferation of neuronal precursors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

N-myc can substitute for insulin-like growth factor signaling in a mouse model of sonic hedgehog-induced medulloblastoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

AXIN1 mutations but not deletions in cerebellar medulloblastomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Nuclear localization and mutation of beta-catenin in medulloblastomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Ku80 and p53 suppress medulloblastoma that arise independent of Rag-1-induced DSBs.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Isolation of neural stem cells from the postnatal cerebellum

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Identification of human brain tumour initiating cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Medulloblastoma: present concepts of stratification into risk groups

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Atypical teratoid/rhabdoid tumor: the controversy behind radiation therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Current treatment approaches to early childhood medulloblastoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Prognostic factors for medulloblastoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Staging, scoring and grading of medulloblastoma. A postoperative prognosis predicting system based on the cases of a single institute.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Medulloblastoma with extensive nodularity: a variant with favorable prognosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Medulloblastomas with systemic metastases: evaluation of tumor histopathology and clinical behavior in 23 patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

c-myc overexpression causes anaplasia in medulloblastoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Prognostic implications of chromosome 17p deletions in human medulloblastomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Molecular insight into medulloblastoma and central nervous system primitive neuroectodermal tumor biology from hereditary syndromes: a review

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

REN(KCTD11) is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Hedgehog checkpoints in medulloblastoma: the chromosome 17p deletion paradigm.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Flow cytometric DNA analysis of medulloblastoma. Prognostic implication of aneuploidy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Prognostic importance of DNA ploidy in medulloblastoma of childhood

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

DNA content and other prognostic features in childhood medulloblastoma. Proposal of a scoring system

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Relation of tumor-cell ploidy to survival in children with medulloblastoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Prognostic factors in medulloblastoma, including DNA ploidy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Potential prognostic value of C-erbB-2 expression in medulloblastomas in very young children.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Clinical and molecular stratification of disease risk in medulloblastoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021

beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0794

7 January 2021